Prof. Ricardo Forastiero

Email: rforastiero@favaloro.edu.ar

Qualifications

Publications(Selected)

1. Palomo IG, Segovia FM, Alarcón ML, Fuentes BY, Pereira JG, Rojas A, Forastiero R. An insight into the pathophysiology of thrombosis in antiphospholipid syndrome. Frontiers in Bioscience 2007, 12: 3093-3103.
2. Forastiero R. Antiphospholipid syndrome: new light comes from in vivo studies. Journal of Thrombosis and Haemostasis 2007, 5 (9): 1825-1827.
3. Puente D, Forastiero R. New insights into the management of antiphospholipid syndrome-related thrombosis. Future Rheumatology 2008, 3(1): 85-93.
4. Forastiero R, Martinuzzo M. Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome. Lupus 2008, 17: 872-877.
5. Forastiero R, Martinuzzo M, de Larrañaga. New insights exploring differences Interaction between antiphospholipid syndrome and infections related antiphospholipid antibodies. En: New Research on Autoantibodies. Claude T. Petrelli, eds. Nova Science Publishers, Inc, ed 2008, chapter 5, pp 131-149. ISBN: 978-1-60456-055-8.
6. de Larrañaga G, Bottaro E, Martinuzzo M, Figueroa R, Iglesias Varela ML, Perés Wingeyer S, Forastiero R, Adamczuk Y, Corti M, Puga L, Benetucci J. Thrombophilia in HIV infected patients with osteonecrosis: is there a real connection? The first case-control study. Clinical and Applied Thrombosis/Hemostasis 2009, 15(3): 340-347.
7. Puente D, Pombo G, Forastiero R. Current management of antiphospholipid syndrome-related thrombosis. Expert Review of Cardiovascular Therapy 2009, 7 (12): 1551-1558.
8. Forastiero R. Antigen specificity of antiphospholipid syndrome-related antiphospholipid antibodies. The Open Autoimmunity Journal 2010, 2: 21-27.
9. Forastiero R. Editorial: News on the antiphospholipid syndrome. The Open Autoimmunity Journal 2010, 2: 17.
10. de Laat B, Derksen RHWM, Reber G, Musial J, Bozie B, Regnault V, Forastiero R, Woodhams BJ, de Groot PH. An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies. Journal of Thrombosis and Haemostasis 2011, 9: 149-153.
11. Bertolaccini ML, Amengual O, Atsumi T, Binder WL, Kutteh WH, de Laat B, Forastiero R, Lambert M, Matsubayashi H, Murthy V, Petri M, Rand J, Sanmarco M, Tebo AE, Pierangeli S. “Non-Criteria” aPL tests: Report of a task force and preconference workshop at the 13^th International Congress on Antiphospholipid Antibodies, Galveston, TX. April 2010. Lupus 2011, 20: 191-205.
12. Forastiero R, Martinuzzo M, de Larrañaga G, Vega-Ostertag M, Pierangeli S. Anti-beta 2 glycoprotein I antibodies from leprosy patients do not show thrombogenic effects in an in vivo animal model. Journal of Thrombosis and Haemostasis 2011, 9 (4): 859-861.
13. Martinuzzo ME, Cerrato GS, Iglesias Varela ML, Adamczuk YP, Forastiero RR. New guidelines for LA: sensitivity and specificity of cut off values calculated with plasmas from healthy controls in mixing and confirmatory tests. International Journal of Laboratory Hematology 2012 (in press).
14. Bertolaccini ML, Amengual O, Atsumi T, Binder WL, Kutteh WH, de Laat B, Forastiero R, Lambert M, Matsubayashi H, Murthy V, Petri M, Rand JH, Sanmarco M, Tebo AE, Pierangeli SS. “Non-Criteria” aPL tests: Report of a task force and preconference workshop at the 13^th International Congress on Antiphospholipid Antibodies, Galveston, TX. April 2011. Chapter 9 (in press).